Design and Conduct of Clinical Trials

[1]  C. Meinert,et al.  The inclusion of women in clinical trials , 1995, Science.

[2]  K. Stanley.  Evaluation of Randomized Controlled Trials , 2007, Circulation.

[3]  J. Wittes,et al.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.

[4]  R. Levine,et al.  The need to revise the Declaration of Helsinki. , 1999, The New England journal of medicine.

[5]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[6]  D. Sackett,et al.  Controversy in counting and attributing events in clinical trials. , 1979, The New England journal of medicine.

[7]  Harlan M Krumholz,et al.  Outcomes Research: Generating Evidence for Best Practice and Policies , 2008, Circulation.

[8]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[9]  Tony Tse,et al.  Reporting "basic results" in ClinicalTrials.gov. , 2009, Chest.

[10]  Persantine‐Aspirin Reinfarction Study: Design, Methods and Baseline Results , 1980, Circulation.

[11]  J. Kestle.  Clinical Trials , 2014, World Journal of Surgery.

[12]  How to read clinical journals: I. why to read them and how to start reading them critically. , 1981, Canadian Medical Association journal.

[13]  L. Sullivan.  Estimation From Samples , 2006, Circulation.

[14]  S Hellman,et al.  Of mice but not men. Problems of the randomized clinical trial. , 1991, The New England journal of medicine.

[15]  M. Zelen.  A new design for randomized clinical trials. , 1979, The New England journal of medicine.

[16]  Cyrus Mehta,et al.  Optimizing Trial Design: Sequential, Adaptive, and Enrichment Strategies , 2009, Circulation.

[17]  R J Lilford,et al.  Equipoise and the ethics of randomization. , 1995, Journal of the Royal Society of Medicine.

[18]  D. Schoenfeld,et al.  Sample-size formula for the proportional-hazards regression model. , 1983, Biometrics.

[19]  Roger B. Davis,et al.  Hypothesis Testing: Means , 2006, Circulation.

[20]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[21]  S. Piantadosi.  Clinical Trials : A Methodologic Perspective , 2005 .

[22]  J. Tukey.  Some thoughts on clinical trials, especially problems of multiplicity. , 1977, Science.

[23]  C. Meinert.  Clinical Trials Dictionary: Terminology and Usage Recommendations , 1996 .

[24]  C. Meinert,et al.  Format-independent data collection forms. , 1995, Controlled clinical trials.

[25]  J. Neaton,et al.  A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group. , 1991, Controlled clinical trials.

[26]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[27]  R. G. Cornell,et al.  Ethics and statistics in randomized clinical trials. , 1991, Statistical science : a review journal of the Institute of Mathematical Statistics.

[28]  D Moher,et al.  CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. , 1998, JAMA.

[29]  J. Cappelleri.  A personal view of some controversies in allocating treatment to patients in clinical trials. , 1996, Statistics in medicine.

[30]  Hypothesis Testing: Proportions , 2006, Circulation.

[31]  S. Kaul,et al.  Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials. , 2007, Progress in cardiovascular diseases.

[32]  R Simon,et al.  A decade of progress in statistical methodology for clinical trials. , 1991, Statistics in medicine.

[33]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[34]  F. R. Packard.  Life and Times of Ambroise Paré , 2009 .

[35]  P. Sieghart,et al.  Computer-aided medical ethics. , 1987, Journal of medical ethics.

[36]  Changing the protocol: a case report from the Macular Photocoagulation Study. Macular Photocoagulation Study Group. , 1984, Controlled clinical trials.

[37]  D. Shimm,et al.  Ethical Issues and Clinical Trials , 1993, Drugs.

[38]  S. Pocock,et al.  Clinical Trials: A Practical Approach , 1984 .

[39]  C L Soskolne,et al.  Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. , 1984, The New England journal of medicine.

[40]  D. Oakes,et al.  Survival Methods: Additional Topics , 2008, Circulation.

[41]  C F Starmer,et al.  Clinical Judgment and Statistics: Lessons from a Simulated Randomized Trial in Coronary Artery Disease , 1980, Circulation.

[42]  Michael J. Campbell,et al.  Statistical tables for the design of clinical trials , 1987 .

[43]  C. Meinert.  Comments on NIH clinical trials valid analysis requirement. , 1995, Controlled clinical trials.

[44]  S. Pocock.  Statistical and ethical issues in monitoring clinical trials. , 1993, Statistics in medicine.

[45]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[46]  R. Wittes,et al.  Research Methods in Clinical Oncology , 1988 .

[47]  Design of forms for clinical trials (3). , 1979, British medical journal.

[48]  J. Haybittle,et al.  Design of forms for clinical trials (2). , 1979, British medical journal.

[49]  J. Feussner,et al.  Suspended judgment. Clinical trials of informed consent. , 1992, Controlled clinical trials.

[50]  John Hoey,et al.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.

[51]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[52]  S. Pocock.  Statistical Aspects of Clinical Trial Design , 1982 .

[53]  F. Mosteller,et al.  Reporting standards and research strategies for controlled trials , 1980 .

[54]  S. Schor.  The University Group Diabetes Program. A statistician looks at the mortality results. , 1971, JAMA.

[55]  R. Schlant,et al.  The Natural History of Coronary Heart Disease: Prognostic Factors After Recovery from Myocardial Infarction in 2789 Men The 5‐year Findings of the Coronary Drug Project prepared for the Coronary Drug Project Research Group bv , 1982, Circulation.

[56]  H. Seltzer.  A Summary of Criticisms of the Findings and Conclusions of the University Group Diabetes Program (UGDP) , 1972, Diabetes.

[57]  Carol R. Horowitz,et al.  Community-Based Participatory Research From the Margin to the Mainstream: Are Researchers Prepared? , 2009, Circulation.

[58]  Christopher Hamlin,et al.  The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990 , 1998 .

[59]  M H Gail,et al.  Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. , 1981, Journal of chronic diseases.

[60]  D. Raghavan.  Clinician surrogates and equipoise: an analogy to lawyers who represent themselves? , 1991, European journal of cancer.

[61]  S. Yusuf,et al.  Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. , 1990, Statistics in medicine.

[62]  H. Sahai,et al.  Formulas and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the matched pair design: a review , 1996, Fundamental & clinical pharmacology.

[63]  Richard K. Rondel,et al.  Clinical Data Management , 1994 .

[64]  C. Meinert,et al.  Content of reports on clinical trials: a critical review. , 1984, Controlled clinical trials.

[65]  W. J. Langford.  Statistical Methods , 1959, Nature.

[66]  Arthur S Slutsky,et al.  Data safety and monitoring boards. , 2004, The New England journal of medicine.

[67]  Kenneth Stanley,et al.  Design of Randomized Controlled Trials , 2007, Circulation.

[68]  J. Melo.  "Multiple Risk Factor Intervention Trial" (MRFIT) , 1998 .

[69]  S. Lagakos.  The challenge of subgroup analyses--reporting without distorting. , 2006, The New England journal of medicine.

[70]  How to read clinical journals: V: To distinguish useful from useless or even harmful therapy. , 1981, Canadian Medical Association journal.

[71]  O'Brien Pc,et al.  The appropriateness of analysis of variance and multiple-comparison procedures. , 1983 .

[72]  Design of forms for clinical trials (1). , 1979, British medical journal.

[73]  C. Meinert.  Redesign of trials under different enrollment mixes. , 1999, Statistics in medicine.

[74]  P. O'Brien,et al.  A multiple testing procedure for clinical trials. , 1979, Biometrics.

[75]  A. Hoes.  Case-control studies. , 1995, The Netherlands journal of medicine.

[76]  Martin G. Larson,et al.  Descriptive Statistics and Graphical Displays , 2006, Circulation.

[77]  Joseph Loscalzo,et al.  Cyclooxygenase inhibition and cardiovascular risk. , 2005, Circulation.

[78]  T. Louis,et al.  Clinical trials : issues and approaches , 1984 .

[79]  W. Silverman.  Human Experimentation: A Guided Step into the Unknown , 1985 .

[80]  C. Meinert.  Clinical trials and treatment effects monitoring. , 1998, Controlled clinical trials.

[81]  E. Shuster.  Fifty years later: the significance of the Nuremberg Code. , 1997, The New England journal of medicine.

[82]  J. Westfall,et al.  Practice-based research--"Blue Highways" on the NIH roadmap. , 2007, JAMA.

[83]  P. Moore.  A Million Random Digits with 100,000 Normal Deviates. , 1955 .

[84]  P. Szilagyi.  Translational research and pediatrics. , 2009, Academic pediatrics.

[85]  B. Rodda,et al.  Clinical trials: Design, conduct, and analysis , 1987 .

[86]  R. P. Schwarz.  Maintaining integrity and credibility in industry-sponsored clinical research. , 1991, Controlled clinical trials.

[87]  P. Meier.  Stratification in the design of a clinical trial. , 1981, Controlled clinical trials.